par Durrmeyer, Xavier;Hummler, Helmut;Sanchez-Luna, Manuel;Carnielli, Virgilio;Field, David;Greenough, Anne;Van Overmeire, Bart ;Jonsson, Baldvin;Hallman, Mikko;Mercier, Jean-Christophe;Marlow, Neil;Johnson, Samantha;Baldassarre, James;European Union Nitric Oxide Study Group,
Référence Pediatrics, 132, 3, page (e695-e703)
Publication Publié, 2013-09
Référence Pediatrics, 132, 3, page (e695-e703)
Publication Publié, 2013-09
Article révisé par les pairs
Résumé : | The European Union Nitric Oxide trial was designed to assess the potential benefits of inhaled nitric oxide (iNO) compared with placebo in infants with respiratory failure. This follow-up study evaluated respiratory, neurodevelopmental, and other outcomes for infants entered into the European Union Nitric Oxide trial to age 2 years. |